Federated Hermes, Inc.

Equities

FHI

US3142111034

Investment Management & Fund Operators

Market Closed - Nyse Other stock markets 21:00:02 02/07/2024 BST			5-day change	1st Jan Change
33.05 ^USD	+0.95%		+1.47%	-2.39%

06-04	AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	CI
06-03	After trial, investors weigh Trump 2.0 factor as election looms	RE

Tranche Update on Federated Investors, Inc.'s Equity Buyback Plan announced on October 27, 2016.

January 27, 2017 at 04:15 pm

From October 27, 2016 to December 31, 2016, the company has repurchased 98,084 shares, representing 0.1% for $2.71 million. With this, the company has completed the repurchase of 98,084 shares, representing 0.1% for $2.71 million under the buyback announced on October 27, 2016.

Latest news about Federated Hermes, Inc.

AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	06-03	CI
After trial, investors weigh Trump 2.0 factor as election looms	06-03	RE
Zenas BioPharma, Inc. announced that it has received $200.145732 million in funding from a group of investors	05-06	CI
Zenas BioPharma, Inc. announced that it expects to receive $200.145732 million in funding	05-02	CI
RBC Capital Cuts Federated Hermes Price Target to $35 From $37, Maintains Sector Perform Rating	04-29	MT
UBS Adjusts Federated Hermes Price Target to $36 From $39, Maintains Neutral Rating	04-29	MT
Transcript : Federated Hermes, Inc., Q1 2024 Earnings Call, Apr 26, 2024	04-26
Tranche Update on Federated Hermes, Inc.'s Equity Buyback Plan announced on October 26, 2023.	04-25	CI
Federated Hermes, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 EPS $0.89	04-25	MT
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 Revenue $396.4M	04-25	MT
Federated Hermes, Inc. Declares Special Dividend, Payable on May 15, 2024	04-25	CI
Federated Hermes, Inc. Declares Quarterly Dividend, Payable on May 15, 2024	04-25	CI
Transcript : Federated Hermes, Inc. - Shareholder/Analyst Call	04-25
UBS Adjusts Federated Hermes Price Target to $39 From $37, Maintains Neutral Rating	04-12	MT
EMEA Morning Briefing : Stocks Seen Lower; Investors Await Fresh Data for Rate Cut Cues	03-26	DJ
EMEA Morning Briefing : Stocks May Ease After Record Highs	03-22	DJ
Policy uncertainty drives investors into US medium-term bond funds	03-20	RE
AstraZeneca AB entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc. for $1.8 billion.	03-18	CI
Regulus Therapeutics Inc. announced that it has received $100.000267 million in funding from a group of investors	03-13	CI
Analysis-Property titans seek clues in Cannes for market turnaround	03-13	RE
Federated Hermes Premier Municipal Income Fund Declares Dividend, Payable on April 1, 2024	03-11	CI
Regulus Therapeutics Inc. announced that it expects to receive $100.000267 million in funding from a group of investors	03-10	CI
Federated Hermes Insider Sold Shares Worth $500,327, According to a Recent SEC Filing	03-07	MT
Xcelerate Pte Ltd announced that it has received $25 million in funding from Federated Hermes, Inc., Altair Capital Advisors Pte Ltd, Exacta Capital Partners, and other investors	02-24	CI

Chart Federated Hermes, Inc.

Duration

Period

More charts

Company Profile

Federated Hermes, Inc. is an investment management company. The Company operates through a single segment, being the investment management business. It sponsors, markets and provides investment-related services to various investment products, including sponsored investment companies and other funds (Federated Hermes Funds); and Separate Accounts, which include separately managed accounts (SMAs), institutional accounts, sub-advised funds and other managed products in both domestic and international markets. In addition, it markets and provides stewardship and real estate development services to various domestic and international companies. The Company provides investment advisory services to approximately 180 Federated Hermes Funds. It markets these funds to institutional customers and banks, broker/dealers and other financial intermediaries who use them to meet the needs of customers and/or clients, including, among others, retail investors, corporations and retirement plans.

Sector

Investment Management & Fund Operators

Calendar

24/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Linda Duessel, Federated Hermes: US-China tension around AI makes investing in China riskier

September 11, 2023 at 09:48 pm

More Strategies

Ratings for Federated Hermes, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

33.05 USD

Average target price

37.12 USD

Spread / Average Target

+12.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Investment Management

	1st Jan change	Capi.
FEDERATED HERMES, INC.	-2.39%	2.65B
BLACKSTONE INC.	-5.89%	93.54B
KKR & CO. INC.	+27.86%	94B
ARES MANAGEMENT CORPORATION	+13.90%	26.98B
LEGAL & GENERAL PLC	-8.38%	16.99B
THE CARLYLE GROUP INC.	-1.67%	14.4B
AMUNDI	+2.19%	13.5B
FRANKLIN RESOURCES, INC.	-25.38%	11.7B
HDFC ASSET MANAGEMENT COMPANY LIMITED	+28.73%	10.48B
BLUE OWL CAPITAL INC.	+17.72%	9.13B

Investment Management